Ads
related to: glaxosmithklineopvee.com has been visited by 10K+ users in the past month
Search results
Akebia stock jumps as FDA clears renal anemia therapy (NASDAQ:AKBA)
Seeking Alpha· 3 hours agoAkebia Therapeutics (AKBA) receives FDA approval for Vafseo tablets, leading to a 25% surge in...
Medicaid change sparks warning for children
Newsweek· 2 days agoA switch in Medicaid's formula could mean many children will go without inhalers in the coming months. The process change means drugmakers have to pay...
Experts say Medicaid rebate change is behind inhaler price cuts | Texarkana Gazette
Texarkana Gazette· 1 day agoThree of the four major inhaler manufacturers have announced plans to cap patient copays for all...
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
CNBC· 2 days agoThree of the world's largest inhaler makers have agreed to cap the out-of-pocket price of their...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 2 days agoChanges were made in response to pressure from lawmakers. Amidst untenable drug prices, there's...
12 Best Biotech Penny Stocks to Invest In
Insider Monkey via Yahoo Finance· 4 days agoIn this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to 5...
U.S. FDA approves Akebia's anemia drug
Reuters via AOL· 12 hours agoThe FDA had earlier declined to approve vadadustat - a Hypoxia-inducible factor–prolyl hydroxylase (HIF-PH) inhibitor - on safety concerns, as it posed...
Amivantamab Offers Post-Progression Benefit in EGFRm NSCLC
Medscape· 8 hours agoEven if patients with EGFR-mutated lung cancer progress on amivantamab plus chemotherapy, there is a...
32 Countries with the Highest Rates of Diabetes
Insider Monkey via Yahoo Finance· 2 days agoIn this article, we will be taking a look at the 32 countries with the highest rates of diabetes. If you do not want to learn about the global diabetes...
No. 7: Doug Langa
NJBIZ· 3 days agoLanga – who previously held positions at GlaxoSmithKline and Johnson & Johnson – has said he believes a “significant portion” of Novo Nordisk’s growth...
Ad
related to: glaxosmithklineopvee.com has been visited by 10K+ users in the past month